126 Enrolled - Astellas EXERRT Study
We completed enrollment for the Astellas EXERRT study!
Two of our sites participated, and both did incredibly well. Katy Cardiology Associates randomized 98 patients to help Astellas reach their world-wide goal of 1130 patients. Northwest Houston Heart Center randomized 28 patients in this same study, also an awesome achievement.
In total, our sites combined for 11.2% of the total worldwide randomized patients in this pivotal clinical trial! An amazing accomplishment which makes our team proud.
The purpose of this study is to demonstrate that the strength of agreement between single photon emission computed tomography (SPECT) imaging with regadenoson following inadequate exercise stress testing and SPECT imaging with regadenoson alone is not inferior to the strength of agreement between two sequential regadenoson SPECT images without exercise.